Indirubin-3-monoxime

CAS No. 667463-82-3

Indirubin-3-monoxime ( —— )

Catalog No. M24681 CAS No. 667463-82-3

Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 132 In Stock
25MG 260 In Stock
50MG 402 In Stock
100MG 593 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Indirubin-3-monoxime
  • Note
    Research use only, not for human use.
  • Brief Description
    Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.
  • Description
    Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    cdk
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    667463-82-3
  • Formula Weight
    277.3
  • Molecular Formula
    C16H11N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc([nH]c1c2cccc1)c2-c([nH]c1c2cccc1)c2N=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dera A A , Rajagopalan P , Fayi M A , et al. Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer[J]. Archives of Pharmacal Research, 2020, 43(10).
molnova catalog
related products
  • CDK9-IN-1

    CDK9-IN-1 is a potent, selective CDK9 inhibitor with IC50 of 39 nM (CDK9/CycT1), >10-fold selectivity over CDK4 and >100-fold over CDK1/2/3/5/6/7, inhibits HIV-1 replication in cellular assays.

  • 4-Methoxybenzoic aci...

    4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.

  • Atuveciclib

    Atuveciclib (BAY-1143572) is a potent, highly selective, orally bioavailable CDK9/P-TEFb inhibitor with IC50 of 6 nM for CDK9/CyclinT1.